Sank Leonard 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Sank Leonard
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 totalExercise: $13.89Exp: 2032-01-03→ Common Stock (10,000 underlying) - Award
Common Stock
2022-01-03+6,000→ 6,000 total
Holdings
- 138,889(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]These shares consist of shares of common stock owned by a company wholly owned by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.
- [F3]The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.